A study to compare the effectivness of two homoeopathic medicines Baryta mur and Rawolfia in Essential Hypertension

Effectiveness of Baryta muriatica 3x in patients with essential hypertension a comparative study with patients on Rauwolfia serpentina 3x. - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106762

Enrollment

Registered

2026-03-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Baryta muriatica 3X : study arm- A will be given Baryta muriatica 3x.3 grain tablet 2 times daily.Each case will be reviewed at every 15 days interval, for period of 6 months. Control I

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients with stage 1 and stage 2 Essential Hypertension 2)Age group between 30-70 years of both sexes and all socioeconomic group 3)Patients who have given consent for the study

Exclusion criteria

Exclusion criteria: 1)Individuals with hypertensive complications and severe co-morbidities 2)Individuals with severe chronic disease 3)Pregnant women and lactating mothers

Design outcomes

Primary

Measure	Time frame
To study the action of Baryta muriatica 3X in controlling blood pressure values in patients with essential hypertension. To study whether Baryta muriatica 3X is more effective than Rauwolfia serpentina 3X in controlling blood pressure values in patients with essential hypertension. Timepoint: Mean Changes in the systolic and diastolic blood pressure from baseline to 6 months after initiation Baryta muriatica 3X and Rauwolfia Serpentina 3X	—

Measure

Time frame

To study the action of Baryta muriatica 3X in controlling blood pressure values in patients with essential hypertension. To study whether Baryta muriatica 3X is more effective than Rauwolfia serpentina 3X in controlling blood pressure values in patients with essential hypertension. Timepoint: Mean Changes in the systolic and diastolic blood pressure from baseline to 6 months after initiation Baryta muriatica 3X and Rauwolfia Serpentina 3X

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Lakshmi G L

Government Homoeopathic Medical College Thiruvananthapuram

lglhomoeo@gmail.com9446338652

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026